Aravind Ganesh
@draravindganesh
Assistant Professor, Stroke & Cognitive Neurologist @DCNSNeuro. CEO @letsgetproof. MD @UCalgaryMed, DPhil (Clin Neuro) @UniofOxford, FRCPC(Neuro) @Royal_College
ID: 2981187099
16-01-2015 14:53:52
2,2K Tweet
1,1K Followers
601 Following
🧵#STROKE Topical Review by Johanna Ospel, MD PhD et al.: Endovascular thrombectomy has revolutionized the landscape for care for patients with ischemic stroke due to large vessel occlusion.
👏🏼 Dr. Michael Hill has been recognized by his peers as one of Canada’s leading researchers in brain health. Thanks UBC Medicine for honouring Dr. Hill’s commitment to advancing stroke research and treatment on a global scale! DCNS Calgary Department of Medicine Hotchkiss Brain Institute (HBI) Libin Cardiovascular Institute
🚨 Is the modified Rankin Scale (mRS) the be-all, end-all of stroke trials, forever and ever? 😁As Johanna Ospel, MD PhD Mayank Goyal and I argue in this paper on pragmatic outcome selection for stroke trials The Lancet Neurology, surely not. See our case study examples thelancet.com/journals/laneu…
Congratulations to Dr. Bijoy Menon for leading a groundbreaking clinical trial on acute ischemic stroke treatment, supported by CIHR's $43M investment! We're proud to see our researchers advancing stroke care. Learn more: bit.ly/4dqtBwb UCalgaryMedicine | DCNS Calgary
Well written critique of an outdated and oversimplified outcome metric by Aravind Ganesh Johanna Ospel, MD PhD Mayank Goyal.
Drs. Aristeidis Katsanos and Ashkan Shoamanesh of McMaster University are leading the CoVasc-ICH study to see if colchicine, a drug that reduces inflammation and clotting, can lower the risk of blood clots, heart attacks, or stroke in hemorrhagic stroke survivors. bit.ly/3WB2J5o?hsid=9…
Human rights should never be ignored when choosing a conference location. The World Stroke congress should never have been held in a location where basic human rights and therefore the safety of participants can not be guaranteed. Stroke Research thelancet.com/journals/lance…
🎥 Aristeidis Katsanos of McMaster University outlines the findings of the CONVINCE trial, a large Phase III international clinical trial investigating colchicine for secondary #Stroke prevention. Watch here: 👉 ow.ly/b8Wz50T9U9G 👈 #ESOC2024 #Neurology #NeuroTwitter #CTSM #TrialUpdate
Are questionnaires looking at extended activities of daily living (ADL) still relevant in 2024. Well... when did YOU last write a cheque, or use a telephone directory. Read more in our just published Age_and_Ageing paper academic.oup.com/ageing/article…
Thrilled to have our work recognized as central in holding a notoriously impervious industry to account time.com/7012875/amba-k… #TIME100AI There's power in saying the unpopular thing, even if there is also discomfort :) Grateful to team AI Now Institute and those we walk with ❤️